trial

Cognitive Remediation in Early Phase Psychosis

NCTId NCT01546467
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Unknown
Enrollment 50 (estimated)
Sponsored by Oslo University Hospital
Primary completion 2013-12
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Unknown
Enrollment
50 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2009-09
Primary completion
2013-12
Eligibility
ALL · 18 Years · 40 Years

Interventions & indications

Drugs
Cognitive Remediation

Sponsors

Oslo University HospitalLead Sponsor
Stiftelsen Helse og RehabiliteringCollaborator
South-Eastern Norway Regional Health AuthorityCollaborator

Investigators

1
Torill Ueland, PhDPrincipal Investigator

Sites

1 total
Oslo, Norway

Facts & assertions

4 sourced
Enrollment
50
Phase
NA
Primary Completion Date
2013-12
Status
UNKNOWN
relationships
The graph out of here
drug
Cognitive Remediation
drug
lead_sponsor
Oslo University Hospital
company
collaborator
Stiftelsen Helse og Rehabilitering
company
South-Eastern Norway Regional Health Authority
company
indication
Schizoaffective Disorder
indication
Psychotic Disorders
indication
Schizophrenia
indication
investigator
Torill Ueland, PhD
person